Drug Trial Radar · NCT03402386
Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Last checked: Nov 20, 2026Latest source record: Apr 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Jan 3, 2018
Primary completion
Nov 22, 2018
Study completion Dec 20, 2018
Sponsor
- Lead sponsor
- Tanabe Pharma CorporationIndustry
- Sponsor type
- Industry
- First posted
- Jan 18, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of MT-6548 in peritoneal dialysis subjects with anemia associated with chronic kidney disease
Conditions
- Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease
Interventions
MT-6548Drug
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Hb Level of Week 20 and Week 24Time frame: Up to Week 24
- Hb Level at Each Assessment Time PointTime frame: Up to Week 24
- Percentage of Subjects With Hb Level at Each Assessment Time Point Within the Target Range During the Treatment PeriodTime frame: Up to Week 24
- Time to Reach the Target Hb Range in Correction Group OnlyTime frame: Up to Week 24
- Rate of Increase in Hb Level in Correction Group OnlyTime frame: Up to Week 6
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Research site
Aichi, Japan
Research site
Chiba, Japan
Research site
Fukuoka, Japan
Research site
Fukushima, Japan
Research site
Gunma, Japan
Research site
Hokkaido, Japan
Research site
Hyōgo, Japan
Research site
Ibaraki, Japan
Research site
Kagoshima, Japan
Research site
Kanagawa, Japan
Research site
Kyoto, Japan
Research site
Nagano, Japan
Research site
Nara, Japan
Research site
Okayama, Japan
Research site
Okinawa, Japan
Research site
Shiga, Japan
Research site
Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.